Guanine triphosphate-cyclohydrolase 1-deficient dopa-responsive dystonia presenting as frequent falling in 2 children

Chang-Yong Tsao1

  • 1Department of Pediatrics and Neurology, The Ohio State University, Columbus, OH 43205, USA. changyong.tsao@nationwidechildrens.org

Journal of Child Neurology
|November 10, 2011
PubMed

Insights

Guanine triphosphate (GTP)-cyclohydrolase 1 (GCH1) deficiency, caused by GCH1 gene mutations, leads to dopa-responsive dystonia. Children with this condition show persistent improvement with low-dose levodopa/carbidopa treatment.

Area of Science:

  • Genetics
  • Neurology
  • Biochemistry

Background:

  • Dopa-responsive dystonia (DRD) is a rare inherited neurological disorder.
  • Mutations in the Guanine triphosphate (GTP)-cyclohydrolase 1 (GCH1) gene are a known cause of DRD.
  • GCH1 encodes the rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, essential for neurotransmitter synthesis.

Observation:

  • Two children presented with frequent daily falls, a significant mobility impairment.
  • Clinical evaluation revealed GCH1 gene mutations in both affected children.
  • Both patients exhibited a persistent positive response to low-dose levodopa/carbidopa therapy.

Findings:

  • The study confirms GCH1 gene mutations as the cause of DRD in these pediatric patients.
  • Persistent therapeutic response to levodopa/carbidopa was observed even at low dosages.
  • Review of typical and atypical clinical features associated with GCH1 mutations was conducted.

Implications:

  • Early diagnosis and treatment of GCH1-deficient DRD can significantly improve patient mobility and quality of life.
  • Low-dose levodopa/carbidopa represents an effective and accessible therapeutic strategy.
  • Understanding the clinical spectrum of GCH1 mutations aids in diagnosing both classic and atypical presentations.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...